Curis | CRIS - Loan Capital


Curis reported $29.43M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Amgen USD 51.86B 27M Jun/2026
AstraZeneca USD 26.01B 46M Jun/2026
Bayer EUR 31.16B 480M Jun/2026
Bristol-Myers Squibb USD 42.09B 59M Jun/2026
CSL USD 10.42B 273M Dec/2025
Curis USD 29.43M 10.69M Jun/2024
Eli Lilly USD 47.86B 8.49B Jun/2026
Gilead Sciences USD 20.86B 1.27B Mar/2026
GlaxoSmithKline GBP 13.95B 65M Jun/2026
Incyte USD 28.42M 994K Jun/2026
Merck USD 51.08B 4.41B Jun/2026
Novartis USD 37.49B 42M Jun/2026
Pfizer USD 60.5B 70M Jun/2026
Roche Holding CHF 25.22B 2.21B Jun/2026
Sanofi EUR 14.65B 806M Jun/2026
Takeda JPY 4.42T 50.32B Jun/2026
TG Therapeutics USD 745.39M 247K Jun/2026
Verastem USD 76.87M 4.46M Mar/2026